JOSEPH SANCHEZ: Open Payments
NPI 1336603331 · SHIRLEY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$487 in 18 payments from 9 companies in 2025. Trend: 2023 $228 · 2024 $0 · 2025 $487
Food & beverage: $487
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 4 | $134 |
| ABBVIE INC. | 4 | $94 |
| Axsome Therapeutics, Inc. | 2 | $61 |
| Janssen Pharmaceuticals, Inc | 1 | $39 |
| Neurocrine BioSciences, Inc. | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 1 | $31 |
| Lundbeck LLC | 1 | $30 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
Products named: FANAPT, VRAYLAR, Auvelity, SPRAVATO, INGREZZA, REXULTI, COBENFY, ABILIFY MAINTENA.
Industry payments across NY — which companies pay providers there.
